FDA Approval Activities for this Drug…

Depakene Capsules, Syrup, Tablets, Sprinkle Capsules, and Depakote ER Tablets, Abbott NDA 18-081/S-038, 18-082/S-024, 18-723/S-029, 19-680/S-015, 20-593/S-009 & 21-168/S-003 12/12/02 1/29/03 Depakote ER (divalproex) Tablets, Abbott NDA 21-168/S7 8/14/03 8/15/03 9/25/03 Depakote ER (divalproex) Extended-Release Tablets, Abbott NDA 20-782 & 21-168/S4 12/20/02 1/29/03 4/4/03 Depakote ER (divalproex) Tablets, Abbott NDA 21-168/S1 5/31/02 6/3/02 5/31/02 Depakote ER (divalproex sodium extended-release) Tablets, 500mg, Abbott NDA 21-168 Divalproex Sodium Delayed-release Tablets,125 mg, 250 mg, and 500 mg, Torpharm ANDA 75-112 DIVALPROEX SODIUM Capsule, Delayed Rel Pellets; 125MG VALPROIC ACID DEPAKOTE Abbott 018723 DIVALPROEX SODIUM Tablet, Delayed Release; 125MG VALPROIC ACID DEPAKOTE Abbott 018723 DIVALPROEX SODIUM Tablet, Delayed Release; 250MG VALPROIC ACID DEPAKOTE Abbott 018723 DIVALPROEX SODIUM Tablet, Delayed Release; 500MG VALPROIC ACID DEPAKOTE Abbott 021168 DIVALPROEX SODIUM Tablet, Extended Release; 250MG VALPROIC ACID DEPAKOTE ER Abbott 021168 DIVALPROEX SODIUM Tablet, Extended Release; 500MG VALPROIC ACID DEPAKOTE ER Abbott

For the latest approval information, please locate this drug using this index.